This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Exopharma, Inc., Spiritus Therapeutics, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Inventor Spotlight: Marilyn Glassberg Csete
Introduction
Marilyn Glassberg Csete, based in Miami, FL, is a prominent inventor recognized for her significant contributions to the field of biomedical innovation. With a focus on advancing therapeutic methods, she has developed pioneering technologies aimed at improving patient outcomes in fibrotic diseases.
Latest Patents
Marilyn holds a notable patent for "Mesenchymal stem cell-derived extracellular vesicles and uses thereof for treating and diagnosing fibrotic diseases." This invention provides advanced compositions and methods designed to treat fibrotic conditions in patients. Specifically, the methods involve administering a therapeutic amount of a pharmaceutical composition that includes synthetic extracellular vesicles (EVs) along with a pharmaceutically acceptable carrier.
Career Highlights
As an inventor, Marilyn has made remarkable strides in the therapeutic landscape, particularly through her work at Spiritus Therapeutics, Inc. Her innovative approach combines scientific rigor with practical applications, showcasing her commitment to enhancing treatment options for patients suffering from fibrotic diseases.
Collaborations
Throughout her career, Marilyn has collaborated with other talented professionals in the field, notably Sharon Elliot and Robin Smith. These partnerships have played a crucial role in the development and refinement of her innovative ideas, further establishing her reputation as a leading figure in her area of expertise.
Conclusion
Marilyn Glassberg Csete exemplifies the spirit of innovation within the biomedical sector. Through her groundbreaking patent and collaborations, she continues to pave the way for advancements in the treatment and diagnosis of fibrotic diseases, demonstrating the impact that a dedicated inventor can have on improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile